Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) shares traded down 3% during trading on Wednesday . The stock traded as low as $5.62 and last traded at $5.80. 50,342 shares changed hands during trading, a decline of 12% from the average session volume of 57,450 shares. The stock had previously closed at $5.98.
Neonc Technologies Price Performance
About Neonc Technologies
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.
Featured Articles
- Five stocks we like better than Neonc Technologies
- Bank Stocks – Best Bank Stocks to Invest In
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
